OriGene To Collaborate With Massachusetts General Hospital To Use OriGene's cDNA Collection

Rockville, MD - OriGene Technologies Inc. recently announced a collaboration with the laboratory of Dr. Brian Seed at the MGH to use OriGene's FlagArray platform for high-throughput functional analysis of genes.

"OriGene has done a wonderful job in creating an outstanding collection of high quality cDNAs in a single expression vector," said Brian Seed, PhD, "We believe OriGene's FlagArray will be an extremely useful resource to help us accelerate our understanding of the function and role of genes in biology in a high throughput and systematic manner."

The OriGene FlagArray(s) are expression-ready arrays of full-length cDNA plasmids for use in highthroughput, genome wide target identification and validation. The arrays allow scientists to easily query thousands of genes and their roles in disease phenotypes and pathways. This platform has been used by several leading pharmaceutical companies providing numerous discoveries. One example of the power of this system can be seen in Proc. Natl. Acad. Sci., 2005, pp 1927-32.

"OriGene's mission is to build the most comprehensive collection of human full-length cDNAs in expression ready vectors and to apply this collection to systematic studies of human gene functions to all researchers," said Karl Kovacs PhD, Vice President of Alliance Management at OriGene. "We are glad to be able to work with Dr. Seed in the further development of the FlagArray platform. The ability to overexpress and test the effects of thousands of proteins will provide deeper understanding of complex intracellular interactions."

For more information visit: OriGene's Website

SOURCE: OriGene Technologies, Inc.